Alecensa 150mg | Alectinib | MHP
ALECENSA 150MG DESCRIPTION Alecensa 150mg consist of second-generation anaplastic lymphoma kinase (ALK) inhibitor authorized by the US Food and Drug Administration to cure crizotinib-refractory non-small cell lung cancer Alecensa 150mg capsule inhibits the developments of cancer cells which are then damaged by the body Alecensa 150mg which is used asprescription drug under the supervision of medical oncologist. alecensa 150mg INDICATION Alecensa 150mg capsule is prescribed for the therapy in patientsaffected by anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC). MECHANISM OF ACTION ALK is a family of proteins known as receptor tyrosine kinases (RTKs), which are included in the growth of cells and the development of new blood vessels which supply them. In patients with ALK-positive NSCLC, an abnormal form of ALK is formedwhichencourage the cancer cells to multiply and grow in an uncontrolled fashion. The active substance in Alecti...